NEUROD1 and small cell lung carcinoma: Further expanding this landscape, recent profiling efforts have proposed additional categories, including an SCLC-AN subtype with co-expression of ASCL1 and NEUROD1, and a quadruple-negative (SCLC-QN) subtype lacking all four canonical biomarkers (36).